Navigation Links
Generex Announces Interview of MD Anderson's Dr. Elizabeth Mittendorf, Principal Investigator on Company's AE37 Phase IIb Breast Cancer Efficacy Trial
Date:6/12/2013

lares the design, clinical endpoints, and statistical analyses acceptable for FDA approval.

Finally, Dr. Mittendorf pointed to the possible real benefit of combining AE37 with other agents, such as immune checkpoint inhibitors.  In particular, inhibitors of PD-1 (programmed cell death protein 1) or CTLA-4 (Cytotoxic T-Lymphocyte Antigen 4) have been shown to essentially take the brakes off the immune system, allowing it to more effectively combat tumor cells in a general way.  As AE37 activates the immune system to specifically attack tumor cells, essentially "stepping on the gas", it is an exciting hypothesis to try combining them.  It should be noted, however, that patients treated with AE37 alone also appear to have "taken the brakes off" the immune system to an extent.

About Generex Biotechnology Corporation

Generex is engaged in the research, development, and commercialization of drug delivery systems and technologies. Generex has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity (with no deposit in the lungs). The Company's proprietary liquid formulations allow drugs typically administered by injection to be absorbed into the body by the lining of the inner mouth using the Company's proprietary RapidMist™ device. Antigen Express, Inc. is a wholly owned subsidiary of Generex. The core platform technologies of Antigen Express comprise immunotherapeutic vaccines for the treatment of malignant, infectious, allergic, and autoimmune diseases. Antigen Express has pioneered the use of specific CD4+ T-helper stimulation technologies in immunotherapy. One focuses on modification of peptides with Ii-Key to increase potency, while a second relies on inhibition of expression of the Ii protein. Antigen Express scientists, and others, have shown clearly that suppression of expression of the Ii protein in cancer cells allows for potent stimulation of T-helper cells and p
'/>"/>

SOURCE Generex Biotechnology Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Generex Announces Presentations of Antigen Express AE37 Breast Cancer Vaccine Data at ASCO 2012
2. Generex Announces New Members of Antigen Express Scientific Advisory Board for the AE37 Breast Cancer Vaccine
3. Generex Augments Antigen Express Scientific Advisory Board
4. Generex Reports on Inaugural AE37 Breast Cancer Vaccine Scientific Advisory Board Meeting
5. Generex Announces OncUView.tv Interviews Featuring the Antigen Express AE37 Breast Cancer Vaccine at ASCO 2012
6. Generex Announces Results of Annual Stockholders Meeting
7. Generex Addresses Recent Trading Volume in Shares of its Common Stock
8. Generex Announces Details of Investor Conference Call
9. Generex Provides an Overview of its Cancer Immunotherapy Product, AE37, and Potential in Early Breast Cancer Given Current and Potential Future Therapies
10. Generex Points to Potential of Antigen Express Technology Platform beyond Its AE37 Breast Cancer Vaccine
11. Generex Touts Pipeline Potential of Antigen Express Subsidiary
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)...  Cumberland Pharmaceuticals (CPIX), today announced that A.J. Kazimi ... on September 10, 2015. DATE: Thursday, September ... http://tinyurl.com/sep10pre This will be a ... ask the company questions in real-time - both in ... trade booth." If attendees are not able to join ...
(Date:9/4/2015)... (NYSE: AGN ) a leading global pharmaceutical company, today ... Allergan, will provide an overview and update of the Company,s ... New York, NY . Logo ... take place on Thursday, September 17, 2015 at 10:35 AM ... 42nd Street, New York, NY 10017.  ...
(Date:9/4/2015)... , Sept. 4, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-nine. ... the Company, commented, "We believe our current pipeline of ...
Breaking Medicine Technology:Cumberland Pharmaceuticals to Webcast, Live, at VirtualInvestorConferences.com September 10 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2
... , , INCLINE VILLAGE, Nev., Dec. 2 PDL ... has established the per share amount of the previously announced $200 ... paid on December 15, 2009 to all holders of the Company,s ... previously estimated the approximate per share amount of the dividend at ...
... , NANJING, China, ... "Company") (NYSE: SCR ), a leading pharmaceutical ... and proprietary pharmaceuticals in China, today reported that its,subsidiary ... suspended production of all its products in order to ...
Cached Medicine Technology:PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 2PDL BioPharma Announces December 15 Special Dividend Payment of $1.67 per Share 3Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 2Simcere Pharmaceutical Group Announces Jiangsu Yanshen's Voluntary Suspension of Production 3
(Date:9/4/2015)... ... ... According to an article published August 18th on Neurology Advisor, ... force that is great enough to cause a traumatic brain injury. This new polymer, ... coaches or officials would instantly see if a player may have suffered a head ...
(Date:9/4/2015)... Diego, California (PRWEB) , ... September 04, 2015 , ... ... on behalf of Tanya De La Paz. , Schmidt National Law Group, a ... the Northern District of California against Bayer Corp., Bayer Essure, Inc., and other Bayer ...
(Date:9/4/2015)... ... September 04, 2015 , ... Inmar announced today that ... of its Product, Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. , ... the consumer goods industry, it can be difficult for companies to navigate, stay ...
(Date:9/4/2015)... ... September 04, 2015 , ... “Getting away from the daily ... to explore, revitalize and strengthen their ‘couple-ness,’” says Jean Claude Wietzel, general manager ... Seasons Resort Maui, the island’s only Forbes Five Star resort and Travel + Leisure’s ...
(Date:9/4/2015)... ... September 04, 2015 , ... The conference ... in Hollywood, Florida October 9-10, 2015 at the Diplomat Resort & Spa has ... are doctors and researchers at the top of their field and will be ...
Breaking Medicine News(10 mins):Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Schmidt National Law Group Files First Bayer Essure® Lawsuit in California 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 2Health News:Couples Season at Four Seasons Resort Maui Begins This Week With Best Hotel Rates of the Year through November 3Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2
... the United States suggests that the odds of firefighters dying ... fire, //are 10 to 100 times higher than during non-emergency ... ,Stefanos Kales of Harvard Medical School and colleagues say ... in smoke, and lack of physical fitness appeared responsible for ...
... a flight attendant. She started exercising two years back and ... keen that she be agile and strong. ,She ... Her exercise regimen includes balancing on one leg, working with ... fall and break her bones. ,Health experts ...
... used ingredient in the Indian curry powder, could be ... ,ASC-J9, a synthetic chemical compound, derived from ... considerable promise against prostate cancer, acne, and enlarged prostate, ... researchers at the University of Rochester Medical Center ...
... Larry E. Miller and team from Virginia Polytechnic Institute and ... men after one year of coronary artery bypass grafting (CABG). ... than one coronary artery which pass through the heart to ... Twenty six men between the ages of 50 and 79 ...
... only recorded case, turns a mild mannered 70-year-old man into a ... his wife have ‘nightmares’ during the day, of the night to ... after, a different person. He shouts, uses the foulest language, sleepwalks, ... Rogers has broken his nose thrice, ...
... people are turning to the Internet to find information, important ... sheer avalanche of facts// now available online. Key science sites ... results. ,New research funded by the Economic and ... Web to make their information available must now pay attention ...
Cached Medicine News:Health News:New Study Reveals That Firefighters Are Prone To Heart Attack 2Health News:Key Science Web Sites Buried in Information Avalanche 2
An enzyme-linked immuno-sorbent assay for the detectionand quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
... Stabilizer Plastazote® with plastic anterior ... straps. Chin cradle reduces rotation. ... be interchanged for individualized fitting.,Philadelphia™ ... standard Philadelphia Collar for added ...
Bougie Urethrotomes for slitting the female urethra and for meatus stenosis in males...
Optical Mini Urethrotome for telescope 3.3 mm, 0...
Medicine Products: